Coherus Oncology, Inc. (NASDAQ:CHRS) Given Consensus Recommendation of "Hold" by Analysts
Shares of Coherus Oncology, Inc. (NASDAQ:CHRS - Get Free Report) have received a consensus rating of "Hold" from the five analysts that are currently covering the firm, Marketbeat Ratings reports...